Word is Spreading Fast

Check out the latest FastWave news within the cardiovascular community.

FastWave Medical Secures Financing to Advance Intravascular Lithotripsy Technology

FastWave Medical Secures Financing to Advance Intravascular Lithotripsy Technology

FastWave Medical announced the closing of the second tranche of its Series Pre-A financing. The funds will be used to further advance research and development for the company’s intravascular lithotripsy (IVL) systems and help the company achieve key regulatory initiatives for its technology platforms.

FastWave Medical Closes Second Tranche of Series Pre-A Financing Led by Grand Pharmaceutical Group

FastWave Medical Closes Second Tranche of Series Pre-A Financing Led by Grand Pharmaceutical Group

Proceeds from the second tranche of funding will be used to further advance research and development for FastWave’s proprietary intravascular lithotripsy (IVL) systems for the treatment of calcific artery disease. The investment will also help the company achieve key regulatory initiatives for its technology platforms.

FastWave Medical Closes Second Tranche of Series Pre-A Financing Led by Grand Pharmaceutical Group Limited

FastWave Medical Closes Second Tranche of Series Pre-A Financing Led by Grand Pharmaceutical Group Limited

The latest phase of financing demonstrates the continued confidence from the company's investor in FastWave’s ability to execute against its development milestones. New financing will further support the development of FastWave’s proprietary intravascular lithotripsy systems.

FastWave Medical Closes Series Pre-A Financing and Milestone-Based Acquisition Agreement

FastWave Medical Closes Series Pre-A Financing and Milestone-Based Acquisition Agreement

FastWave Medical Inc., a company incubated by partners of Big Sky Biomedical, announced today the closing of its Series Pre-A financing, led by a strategic partner from Asia. FastWave Medical is focused on providing endovascular solutions for arterial disease.